ashbaugh
colleagu
first
describ
respiratori
distress
syndrom
patient
acut
onset
tachypnea
refractori
hypoxemia
loss
lung
complianc
diffus
alveolar
infiltr
chest
xray
cxr
note
patient
featur
similar
infantil
respiratori
distress
syndrom
respond
standard
treatment
year
mani
differ
definit
acut
respiratori
distress
syndrom
ard
propos
american
european
consensu
confer
aecc
commonli
use
past
berlin
definit
tabl
commonli
use
present
berlin
definit
ard
publish
endors
european
societi
intens
care
medicin
esicm
american
thorac
societi
at
societi
critic
care
medicin
sccm
defin
ard
new
worsen
respiratori
symptom
within
week
clinic
insult
bilater
opac
cxr
fig
computer
tomographi
ct
scan
fig
fulli
explain
cardiac
failur
fluid
overload
classifi
ard
three
categori
tabl
base
arteri
oxygen
tension
fraction
inspir
oxygen
ratio
minimum
posit
endexpiratori
pressur
peep
berlin
definit
notabl
differ
prior
definit
recogn
ct
scan
use
lieu
chest
radiograph
acknowledg
diagnosi
occur
presenc
cardiac
failur
includ
minimum
peep
cm
cpap
mild
ard
berlin
definit
simplifi
prior
definit
remov
classif
acut
lung
injuri
ali
instead
util
mild
moder
sever
ard
classif
classif
remain
import
definit
ard
due
differ
mortal
well
treatment
option
mani
studi
investig
incid
ard
acut
respiratori
failur
intern
report
nation
heart
lung
institut
reveal
incid
ard
usa
populationyear
acut
lung
injuri
epidemiolog
natur
histori
alien
studi
evalu
patient
data
spain
estim
incid
populationyear
icu
mortal
despit
lung
protect
ventil
broader
studi
look
icu
across
differ
countri
conclud
ard
repres
total
icu
admiss
patient
mechan
ventil
also
note
ard
continu
underdiagnos
patient
qualifi
ard
berlin
definit
recogn
clinician
risk
factor
ard
includ
direct
indirect
lung
injuri
direct
lung
injuri
occur
pneumonia
bacteri
viral
fungal
opportunist
gastric
content
aspir
pulmonari
contus
inhal
injuri
drown
indirect
lung
injuri
includ
sepsi
trauma
pancreat
burn
drug
overdos
transfusionrel
acut
lung
injuri
trali
major
ard
case
relat
pneumonia
gastric
aspir
sepsi
asid
lung
injuri
hypothes
genet
predisposit
may
increas
risk
develop
ard
although
singl
gene
identifi
culprit
gene
associ
ard
includ
angiotensinconvert
enzym
ace
epiderm
growth
factor
egf
factor
v
surfact
protein
b
tumor
necrosi
factoralpha
tnf
tolllik
receptor
among
other
ace
clearest
associ
ard
came
light
identifi
vitro
studi
potenti
receptor
coronaviru
caus
sar
confirm
show
express
cell
initi
suscept
sar
infect
would
allow
entri
viru
cell
led
possibl
recombin
protein
potenti
treatment
prevent
spread
sar
protect
infect
patient
worsen
lung
failur
studi
also
conduct
better
defin
role
emerg
lung
infect
avian
influenza
ard
consist
three
distinct
phase
exud
phase
prolif
phase
fibrot
phase
exud
phase
occur
within
day
initi
insult
lung
initi
insult
may
direct
insult
alveolar
epithelium
pneumonia
indirect
insult
pancreat
phase
character
immun
cellmedi
damag
alveolar
capillari
endotheli
cell
alveolar
epitheli
cell
result
loss
alveolar
barrier
accumul
proteinrich
edema
format
proteinrich
hyalin
membran
alveolar
macrophag
secret
cytokin
tumor
necrosi
factoralpha
lipid
mediat
respons
proinflammatori
cytokin
neutrophil
recruit
area
well
activ
alveolar
epitheli
cell
effector
tcell
lead
sustain
inflamm
tissu
injuri
result
inflammatori
exud
directli
affect
type
ii
alveolar
cell
lead
inactiv
surfact
impair
alveolar
function
cascad
injuri
decreas
pulmonari
complianc
lead
worsen
ga
exchang
increas
mismatch
refractori
hypoxia
worsen
mechan
stretch
injuri
prolif
phase
ard
occur
day
attempt
repair
damag
exud
phase
occur
macrophag
transit
macrophag
help
clear
debri
inflammatori
process
also
lead
signal
type
ii
alveolar
cell
stimul
fibrin
matrix
scaffold
synthes
surfact
differenti
type
alveolar
cell
epitheli
line
recov
protein
channel
tight
junction
reestablish
help
remov
alveolar
edema
final
phase
ard
fibrot
phase
consist
occur
patient
phase
consist
extens
alveolar
duct
interstiti
fibrosi
emphysemalik
chang
observ
destruct
pulmonari
vasculatur
fibrosi
lead
increas
pulmonari
hypertens
phase
associ
signific
increas
mortal
may
requir
longterm
support
mechan
ventil
ard
network
ardsnet
group
network
clinic
site
initi
nation
heart
lung
blood
institut
nhlbi
nation
institut
health
nih
encompass
year
research
includ
patient
consortium
establish
hasten
develop
therapi
ard
includ
numer
trial
evalu
use
fluid
statin
albuterol
steroid
nutrit
one
influenti
studi
one
much
current
strategi
lung
protect
ventil
come
landmark
ventil
lower
tidal
volum
compar
tradit
tidal
volum
acut
lung
injuri
ard
arma
studi
publish
ardsnet
group
arma
studi
look
patient
mechan
ventil
due
either
acut
lung
injuri
ard
patient
random
receiv
higher
tidal
volum
ventil
mlkg
ideal
bodi
weight
plateau
pressur
cm
low
tidal
volum
ventil
mlkg
ideal
bodi
weight
plateau
pressur
cm
studi
stop
earli
due
reduct
mortal
low
tidal
volum
ventil
group
vs
led
belief
higher
tidal
volum
ventil
lead
worsen
pulmonari
edema
due
alveolar
overdistent
caus
addit
damag
endotheli
epitheli
line
promot
proinflammatori
cascad
high
tidal
volum
group
studi
significantli
higher
typic
use
studi
offer
evid
show
mechan
ventil
low
tidal
volum
reduct
mortal
also
much
debat
mechan
ventil
mode
best
suit
patient
ard
howev
cochran
review
three
random
control
trial
includ
patient
show
evid
suggest
advantag
use
pressurecontrol
volumecontrol
ventil
ideal
peep
set
ard
also
controversi
like
vari
patient
higher
peep
minim
dead
space
alveolar
stretch
lead
decreas
venou
return
howev
peep
drop
atelectasi
worsen
recommend
minimum
peep
cm
use
goal
minim
trauma
induc
repetit
open
close
alveoli
metaanalysi
three
random
control
trial
show
mortal
increas
lower
valu
peep
patient
moder
sever
ard
multipl
method
suggest
determin
optim
peep
common
method
titrat
base
lov
lung
open
ventil
decreas
mortal
acut
respiratori
distress
syndrom
studi
compar
patient
receiv
convent
level
peep
receiv
higher
level
studi
show
signific
differ
allcaus
mortal
barotrauma
two
arm
howev
higher
peep
strategi
appear
improv
secondari
end
point
ardsnet
protocol
includ
lower
peep
higher
peep
strategi
seen
tabl
util
achiev
oxygen
goal
arteri
blood
ga
mmhg
oxygen
satur
goal
set
ventil
lower
tidal
volum
often
necessari
allow
permiss
hypercapnia
often
caus
respiratori
acidosi
anoth
method
peep
select
base
posit
endexpiratori
pressur
set
adult
acut
lung
injuri
acut
respiratori
distress
syndrom
express
trial
increas
peep
stepwis
manner
maintain
constant
tidal
volum
inspiratori
plateau
pressur
cm
subgroup
metaanalysi
alveoli
express
lov
trial
suggest
surviv
benefit
use
higher
peep
patient
ratio
esophag
pressureguid
ventil
epvent
trial
conduct
determin
effect
transpulmonari
pressuredirect
control
mechan
ventil
relat
ardsnet
mlkg
tidal
volum
although
explicitli
look
peep
trial
result
patient
within
control
arm
higher
level
peep
better
outcom
second
trial
current
underway
evalu
similar
effect
higher
peep
strategi
confus
matter
alveolar
recruit
acut
respiratori
distress
syndrom
trial
art
publish
trial
enrol
patient
ratio
compar
low
peep
strategi
use
low
peep
tabl
alveoli
lov
trial
stepwis
titrat
peep
use
recruit
maneuv
interestingli
trial
show
higher
rate
mortal
experiment
arm
quantit
analysi
ct
scan
imag
lung
patient
ard
led
concept
babi
lung
analysi
shown
ard
homogen
distribut
rather
consist
portion
lung
normal
aerat
portion
complet
depriv
aerat
result
small
portion
lung
must
fulfil
ventil
requir
individu
research
amato
colleagu
use
concept
suggest
tidal
volum
base
ideal
bodi
weight
ibw
reflect
lung
volum
healthi
individu
take
account
function
lung
patient
ard
significantli
reduc
babi
lung
suggest
take
account
lower
respiratorysystem
complianc
cr
function
lung
ratio
lung
volum
base
ibw
vt
provid
better
predict
outcom
defin
ratio
drive
pressur
vtcr
calcul
bedsid
plateau
pressur
minu
posit
endexpiratori
pressur
pplat
peep
review
patient
nine
differ
trial
conclud
higher
mortal
rate
associ
patient
higher
drive
pressur
also
note
protect
benefit
higher
peep
seen
associ
lower
drive
pressur
analysi
suggest
drive
pressur
cm
may
increas
mortal
ongo
trial
evalu
benefit
reduc
drive
pressur
ard
patient
prone
sever
ard
patient
proseva
trial
multicent
rct
patient
sever
ard
mm
hg
show
compar
supin
posit
signific
reduct
mortal
prone
posit
prone
vs
supin
trial
util
prone
posit
minimum
consecut
hour
per
day
place
patient
prone
posit
reduc
pleural
pressur
gradient
nondepend
depend
region
allow
homogen
distribut
aerat
strain
dorsal
ventral
area
lung
thu
protect
lung
ventilatorinduc
lung
injuri
vili
allow
improv
vq
match
absolut
contraind
prone
posit
includ
limit
pregnanc
spinal
instabl
increas
intracrani
pressur
shock
anterior
burn
chest
tube
hemodynam
instabl
map
mmhg
may
consid
rel
contraind
although
prone
posit
becom
common
throughout
critic
care
unit
challeng
still
exist
implement
one
import
factor
success
implement
remain
physician
nurs
train
order
familiar
process
prone
posit
result
unintend
endotrach
extub
oxygen
transient
decreas
prone
particular
turn
process
reflect
failur
prone
often
transient
phenomenon
addit
chest
wall
complianc
significantli
reduc
prone
posit
may
attribut
decreas
complianc
rib
cage
diaphragmat
compon
chest
wall
spontan
breath
mechan
ventil
particular
sever
ard
neg
consequ
dyssynchroni
gener
high
transpulmonari
pressur
may
increas
risk
vili
use
paralyt
agent
improv
synchroni
lower
oxygen
consumpt
respiratori
muscl
acurasi
trial
look
effect
cisatracurium
neuromuscular
block
agent
h
trial
show
compar
placebo
significantli
lower
adjust
mortal
cisatracurium
group
increas
ventilatorfre
day
decreas
icu
day
trial
also
show
patient
cisatracurium
less
barotrauma
pneumothorac
signific
differ
icuacquir
paresi
despit
studi
societi
critic
care
medicin
comment
use
neuromuscular
block
agent
recent
ard
guidelin
much
interest
studi
effect
corticosteroid
ard
hope
reduc
inflamm
process
unfortun
studi
shown
clear
evid
benefit
steroid
use
meduri
show
may
reduct
icu
mortal
use
methylprednisolon
earli
phase
ard
howev
multipl
subsequ
studi
abl
demonstr
evid
support
efficaci
use
steroid
ard
ardsnet
steroid
studi
show
increas
mortal
patient
start
steroid
day
onset
symptom
fluid
cathet
treatment
trial
ard
factt
look
outcom
patient
ard
resuscit
either
conserv
liber
fluid
regimen
although
studi
show
differ
mortal
rate
patient
receiv
conserv
fluid
manag
reduct
durat
mechan
ventil
icu
day
interestingli
studi
also
look
use
central
venou
pressur
pulmonari
capillari
wedg
pressur
pcwp
guid
fluid
resuscit
like
mani
studi
conclud
use
pulmonari
arteri
cathet
improv
outcom
great
interest
util
venoven
extracorpor
membran
oxygen
vvecmo
patient
sever
respiratori
failur
vvecmo
mode
ecmo
specif
provid
support
lung
oxygen
blood
remov
carbon
dioxid
extern
efficaci
econom
assess
convent
ventilatori
support
versu
extracorpor
membran
oxygen
sever
adult
respiratori
failur
cesar
trial
look
util
transfer
patient
sever
respiratori
failur
murray
score
uncompens
hypercapnia
ph
ecmo
center
studi
show
compar
convent
ventil
manag
surviv
without
sever
disabl
higher
patient
transfer
ecmo
center
vs
show
increas
surviv
receiv
ecmo
compar
time
public
insuffici
evid
make
guidelin
recommend
use
ecmo
patient
ard
nutrit
play
vital
role
recoveri
critic
ill
patient
asid
obviou
benefit
nutrit
enter
feed
advantag
continu
stimul
gut
reduc
risk
infect
bacteri
transloc
eden
trial
conduct
ardsnet
group
look
differ
trophic
full
enter
feed
first
day
treatment
patient
receiv
full
enter
feed
trophic
trickl
feed
defin
rate
kcalh
wherea
full
enter
feed
defin
rate
kcalh
studi
show
differ
outcom
ventilatorfre
day
mortal
infect
two
group
howev
note
full
enter
feed
group
higher
incid
gastrointestin
intoler
result
emesi
higher
gastric
residu
patient
enrol
eden
trial
also
initi
concurr
enrol
omega
trial
look
benefit
omega
acid
howev
trial
stop
earli
due
futil
interim
analysi
show
absolut
increas
mortal
treatment
group
vs
mani
studi
look
treatment
modal
ard
shown
much
benefit
may
caus
harm
modal
highfrequ
oscillatori
ventil
hfov
research
emerg
regard
increas
damag
lung
overstretch
repetit
collaps
alveoli
thought
patient
may
benefit
extrem
low
tidal
volum
provid
hfov
mlkg
high
rate
cochran
review
random
control
trial
hfov
patient
moder
sever
ard
conclud
use
highfrequ
oscil
show
signific
differ
hospit
mortal
one
trial
includ
review
termin
earli
multipl
intrial
analysi
show
use
hfov
increas
mortal
rate
inhal
nitric
oxid
ino
potent
pulmonari
vasodil
use
treatment
pulmonari
hypertens
thought
improv
oxygen
patient
ard
improv
blood
flow
healthi
portion
lung
unfortun
multipl
trial
summar
cochran
review
show
evid
improv
surviv
use
ino
expos
patient
advers
effect
hypotens
renal
failur
albuterol
treatment
ali
alta
trial
conduct
ardsnet
group
look
use
aerosol
albuterol
agonist
shown
antiinflammatori
effect
lung
experiment
ali
anticip
sever
lung
injuri
would
reduc
due
reduct
permeabilityinduc
lung
injuri
howev
trial
termin
earli
due
futil
show
benefit
end
point
similarli
anoth
trial
lung
injuri
trial
baltiii
termin
earli
interim
analysi
show
increas
mortal
broad
clinic
guidelin
establish
regard
treatment
ard
esicm
at
sccm
releas
practic
guidelin
statement
may
address
mechan
ventil
adult
patient
ard
though
limit
strongli
recommend
use
lung
protect
ventil
strategi
util
low
tidal
volum
low
plateau
pressur
use
prone
posit
hday
sever
ard
addit
recommend
consider
use
higher
peep
recruit
maneuv
patient
moder
sever
ard
practic
guidelin
recommend
use
highfrequ
oscillatori
ventil
equivoc
use
ecmo
state
addit
evid
necessari
make
definit
recommend
acut
respiratori
distress
syndrom
result
direct
indirect
insult
alveolar
epithelium
result
damag
alveolar
capillari
cellsacut
respiratori
distress
syndrom
remain
underdiagnos
icu
mortal
mainstay
treatment
acut
respiratori
distress
syndrom
support
care
lung
protect
mechan
ventil
